Interrogating Cancer Drivers via CRISPR: Mutant TP53 as a Therapeutic Target in Hypodiploid B-cell Acute Lymphoblastic Leukemia You are invited to a free webinar featuring Dr. Ernesto Diaz-Flores, a pediatric oncologist from the University of California at San Francisco. In this one hour telecast, Dr. Diaz-Flores will speak to the challenges and opportunities behind creating […]
LevitasBio is excited to be a part of EACR 2022 this year. Our team is looking forward to meeting with you in booth #53 (second floor) to discuss your challenges with dissociated tumor samples and other similar sample types. Come by and learn how levitation technology may be the solution you have been looking for!
LevitasBio is excited to be a part of the British Association for Cancer Research! Come by and learn more about our disruptive solutions and how they have impacted cancer research. We look forward to meeting you at booth #3.
We look forward to meeting you at the upcoming Precision Medicine World Congress (PMWC) 2022 in the heart of Silicon Valley, CA. Visit our booth D2818, or Innovation Showcase on Wednesday to learn more about our levitation technology. If you work with cells, whether its single cell applications, cell line development, pdx engraftment, or even […]
We look forward to meeting you at the upcoming Flow Cytometry UK! In addition to the exhibit booth, our team will be hosting a commercial workshop where you can see our system in person. Details below: Commercial Workshop: Wednesday, July 20 1515 - 1615 pm Elgar Suite Our on-site team: James Williams […]
LevitasBio looks forward to meeting you at Johns Hopkin's 2nd Annual Single Cell Symposium on September 29-30, 2022 in the Turner Concourse. Attend our company showcase to learn how our novel cell enrichment technology elevates your single cell work by: Uncovering native scRNA-seq transcriptomic signatures Enriching the highest quality cells and robust scRNA data Enabling […]
